Immunostimulatory colloidal delivery systems for cancer vaccines

By Saupe Anne   McBurney Warren   Rades Thomas   Hook Sarah  

Expert Opinion on Drug Delivery, Vol. 3, Iss. 3, 2006-05 ,pp. : 345-354

Informa Healthcare

Access to resources Recommend Favorite

Stabilization of vaccines: to be or not to be

By Arya S.C.  

Vaccine, Vol. 19, Iss. 4, 2000-10 ,pp. : 595-597

Elsevier

Access to resources Recommend Favorite

Comparison of the effect of different immunological adjuvants on the antibody and T-cell response to immunization with MUC1-KLH and GD3-KLH conjugate cancer vaccines

By Kim S.K.   Ragupathi G.   Musselli C.   Choi S.-J.   Park Y.S.   Livingston P.O.  

Vaccine, Vol. 18, Iss. 7, 1999-11 ,pp. : 597-603

Elsevier

Access to resources Recommend Favorite

Dendritic cell KLH loading requirements for efficient CD4 + T-cell priming and help to peptide-specific cytotoxic T-cell response, in view of potential use in cancer vaccines

By Millard A.L.   Ittelet D.   Schooneman F.   Bernard J.  

Vaccine, Vol. 21, Iss. 9, 2003-02 ,pp. : 869-876

Elsevier

Access to resources Recommend Favorite

Microparticles for oral delivery of vaccines

By Mutwiri George   Bowersock Terry L   Babiuk Lorne A  

Expert Opinion on Drug Delivery, Vol. 2, Iss. 5, 2005-09 ,pp. : 791-806

Informa Healthcare

Access to resources Recommend Favorite